Literature DB >> 9783921

Long-term outcome of caliceal diverticula following percutaneous endosurgical management.

A L Shalhav1, J J Soble, S Y Nakada, J S Wolf, B L McClennan, R V Clayman.   

Abstract

PURPOSE: We review the morbidity and long-term outcome of percutaneous caliceal diverticulectomy and associated stone extraction.
MATERIALS AND METHODS: Percutaneous caliceal diverticulectomy was performed in 19 women and 11 men (age range 20 to 58 years), of whom 26 had stones (all 15 mm. or less). The diverticula were located throughout the kidney, including the upper (11 patients), middle (15) and lower (4) calices. Percutaneous caliceal diverticulectomy included 28 direct and 2 indirect accesses (1 via a previously placed nephrostomy tract and 1 due to stones in other areas of the kidney). In all cases the stone was removed and the diverticular neck was incised or dilated. Fulguration of the diverticular walls was performed in 22 cases. Transdiverticular percutaneous renal and ureteral drainage was maintained from 2 to 7 days until a nephrostogram demonstrated no extravasation.
RESULTS: The average operating room time and hospital stay were 171 minutes (range 75 to 330) and 4.1 days (range 2 to 7), respectively. Major complications occurred in 6.6% of the cases, requiring 1 blood transfusion and 1 chest tube placement, and minor complications occurred in 13.4%. There was no mortality. Followup for more than 1 year was available in 27 patients. Stone-free rate was 93% with obliteration of the diverticulum in 76% of patients. Overall, 85% of patients are asymptomatic at average followup of 3.5 years (range 1 to 7.3).
CONCLUSIONS: Direct percutaneous endosurgical management provides a safe, efficacious and durable means of treating stone bearing caliceal diverticula, regardless of stone size or location of the diverticulum.

Entities:  

Mesh:

Year:  1998        PMID: 9783921

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  13 in total

Review 1.  Lasers in percutaneous renal procedures.

Authors:  Nadya M Cinman; Sero Andonian; Arthur D Smith
Journal:  World J Urol       Date:  2009-06-02       Impact factor: 4.226

2.  Difficulties with access in percutaneous renal surgery.

Authors:  Soroush Rais-Bahrami; Justin I Friedlander; Brian D Duty; Zeph Okeke; Arthur D Smith
Journal:  Ther Adv Urol       Date:  2011-04

3.  Retrograde intrarenal surgery in the management of symptomatic calyceal diverticular stones: a single center experience.

Authors:  Xiong Chen; Dongjie Li; Yuanqing Dai; Yao Bai; Qizhan Luo; Zhongwei Zhao; Hequn Chen; Xiaobo Zhang
Journal:  Urolithiasis       Date:  2015-07-03       Impact factor: 3.436

Review 4.  Calyceal diverticula: a comprehensive review.

Authors:  Nikhil Waingankar; Samih Hayek; Arthur D Smith; Zeph Okeke
Journal:  Rev Urol       Date:  2014

5.  Percutaneous nephroscopic surgery.

Authors:  Tae-Kon Hwang
Journal:  Korean J Urol       Date:  2010-05-19

6.  The role of laparoscopic surgery for renal calculi management.

Authors:  Kittinut Kijvikai
Journal:  Ther Adv Urol       Date:  2011-02

7.  Percutaneous management of caliceal diverticuli.

Authors:  Amy E Krambeck; James E Lingeman
Journal:  J Endourol       Date:  2009-10       Impact factor: 2.942

8.  Management of calyceal diverticular calculi: a comparison of percutaneous nephrolithotomy and flexible ureterorenoscopy.

Authors:  Okan Bas; Ekrem Ozyuvali; Yasin Aydogmus; Nevzat Can Sener; Onur Dede; Serhat Ozgun; Fatih Hizli; Cagri Senocak; Omer Faruk Bozkurt; Halil Basar; Abdurrahim Imamoglu
Journal:  Urolithiasis       Date:  2014-09-24       Impact factor: 3.436

9.  Percutaneous holmium laser fulguration of calyceal diverticula.

Authors:  Amjad Alwaal; Raed A Azhar; Sero Andonian
Journal:  Case Rep Urol       Date:  2012-02-13

10.  Percutaneous nephrolithotomy: Current concepts.

Authors:  Fabio C Vicentini; Cristiano Mendes Gomes; Alexandre Danilovic; Elias A Chedid Neto; Eduardo Mazzucchi; Miguel Srougi
Journal:  Indian J Urol       Date:  2009-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.